GENTA INCORPORATED /DE/
8-K, 1997-04-15
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: EAGLE FINANCIAL SERVICES INC, 10-K405, 1997-04-15
Next: DISCOVER CARD TRUST 1991 E, 8-K, 1997-04-15




                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT




     PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934



Date of Report (Date of earliest event reported): March 19, 1997




                               GENTA INCORPORATED
             (Exact name of registrant as specified in its charter)


                         Commission file number 0-19635


            DELAWARE                                      33-0326866
 (State or other jurisdiction of           (IRS Employer Identification Number)
 incorporation or organization)



                 3550 GENERAL ATOMICS COURT, SAN DIEGO, CA 92121
                    (Address of principal executive offices)
                                   (Zip Code)



                                 (619) 455-2700
              (Registrant's telephone number, including area code)




<PAGE>

                               GENTA INCORPORATED

                                    FORM 8-K

                                 CURRENT REPORT

                                TABLE OF CONTENTS


Item 5.  Other Events

Signature


                                      - 2 -


<PAGE>


ITEM 5.  OTHER EVENTS

         On February 6, 1997, the Company announced that,  effective February 7,
1997, the Company's Common Stock, formerly listed on The Nasdaq National Market,
would be listed on The  Nasdaq  SmallCap  Market via an  exception  from the bid
price and capital and surplus  requirements of The Nasdaq SmallCap  Market.  The
Nasdaq  Listing  Qualifications  Panel  (the  "Panel")  granted  the  Company  a
temporary  exception  (the  "Exception")  from  these  standards  subject to the
Company's meeting certain conditions.

         By letter dated March 19, 1997,  an  Associate  General  Counsel of The
Nasdaq Stock  Market,  Inc.  informed  the Company  that the Nasdaq  Hearing and
Review  Committee  ("Review  Committee")  had  called  for  review  the  Panel's
decision,  and  that  the  Review  Committee  will  likely  issue  its  decision
subsequent to the next general  meeting of the NASD Board of Governors  which is
currently  scheduled  for June 26, 1997.  The Company has been informed that the
Review  Committee  may  uphold,  reverse or modify the  Panel's  decision in any
manner it deems  appropriate,  and that the  pendency of the Review  Committee's
review does not act as a stay of the Panel's decision.

         On April  11,  1997,  the  Company  was  notified  that the  Panel  had
determined  to modify  the  terms of the  Exception  as  follows  (the  "Revised
Exception").  First, on or before April 15, 1997, the Company must make a public
filing  with the  Securities  and  Exchange  Commission  (the  "SEC") and Nasdaq
evidencing minimum capital and surplus of $2,700,000.  The filing must contain a
February 28, 1997 balance sheet with pro forma  adjustments  for any significant
transactions occurring on or before the filing date. Second, on or before May 7,
1997,  the Company  must  provide  Nasdaq with an April 30, 1997  balance  sheet
evidencing  compliance with the $1,000,000  maintenance  requirement for capital
and surplus.  Third,  on or before June 9, 1997, the Company must provide Nasdaq
with a May 31, 1997 balance  sheet  evidencing  compliance  with the  $1,000,000
maintenance  requirement for capital and surplus.  Finally, on or before July 7,
1997, the Company must make a public filing with the SEC and Nasdaq containing a
June 30,  1997  balance  sheet with pro forma  adjustments  for any  significant
transactions  occurring on or before the filing date. The filing must evidence a
minimum  of  $6,000,000  in  capital  and  surplus  and   compliance   with  all
requirements for continued  listing.  The Panel has further informed the Company
that in the event  the  Company  fails to meet any of the terms of this  Revised
Exception,  its  securities  will be  immediately  deleted from The Nasdaq Stock
Market.  The  Company  believes  that it will be able to meet  the  terms of the
Revised Exception.  However, there can be no assurance that Nasdaq's capital and
surplus requirements will be satisfied or that the Company will not fail to meet
some other listing maintenance standard during the intervening period.

         In  accordance  with the Revised  Exception,  the  Company's  unaudited
condensed  consolidated  balance sheet as at February 28, 1997,  showing capital
and surplus of $2,722,091, is included in this filing.


                                      - 3 -


<PAGE>


                                    SIGNATURE


         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                             GENTA INCORPORATED



Date:  April 15, 1997                        /s/Thomas H. Adams
                                             ----------------------
                                             Thomas H. Adams
                                             Chairman of the Board,
                                             Chief Executive Officer, and
                                             Acting Chief Financial Officer


                                      - 4 -
<PAGE>


                               GENTA INCORPORATED
                      CONDENSED CONSOLIDATED BALANCE SHEET
                                   (UNAUDITED)
<TABLE>
<CAPTION>

                                                                                                       FEBRUARY 28,
                                            ASSETS                                                         1997
                                                                                                   ---------------------
                                                                                                   
Current assets:
<S>                                                                                                  <C>          
   Cash and cash equivalents .....................................................................   $   1,886,949
   Trade accounts receivable .....................................................................         889,254
   Notes receivable from officers and employees ..................................................          62,000
   Inventories ...................................................................................       1,071,860
   Other current assets ..........................................................................         158,262
                                                                                                     -------------
Total current assets .............................................................................       4,068,325
                                                                                                     -------------
Property and equipment, net ......................................................................       3,431,986
Intangibles, net .................................................................................       4,009,083
Other assets, net ................................................................................       1,159,273
                                                                                                     -------------
                                                                                                     $  12,668,667
                                                                                                     =============

                          LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
   Accounts payable ..............................................................................   $   2,226,702
   Other accrued expenses ........................................................................       1,341,407
   Deferred revenue ..............................................................................         134,641
   Short term notes payable ......................................................................       3,350,000
   Current portion of notes payable and
      capital lease obligations ..................................................................         260,301
                                                                                                     -------------
Total current liabilities ........................................................................       7,313,051
                                                                                                     -------------
Notes payable, less current portion ..............................................................         990,365
Deficit in joint venture .........................................................................       1,643,160
Stockholders' equity:
   Preferred stock; 5,000,000 shares authorized:
      Series A convertible preferred stock, $.001 par value; 528,100 shares issued and outstanding
        at February 28, 1997 .....................................................................             528
      Series C convertible preferred stock, $.001 par value; 1,424 shares issued and
        outstanding at February 28, 1997 .........................................................               1
   Common stock, $.001 par value; 150,000,000 shares authorized; 39,991,626 shares
      issued and outstanding at February 28, 1997 ................................................          39,992
   Additional paid-in capital ....................................................................     108,403,272
   Accumulated deficit ...........................................................................    (109,726,538)
   Notes receivable from stockholders ............................................................         (49,976)
   Accrued dividends payable .....................................................................       4,054,812
                                                                                                     -------------
Total stockholders' equity .......................................................................       2,722,091
                                                                                                     -------------
                                                                                                     $  12,668,667
                                                                                                     ==============
</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission